Targeted discovery of gut microbiome-remodeling compounds for the treatment of systemic inflammatory response syndrome/Experiment 22/Signature 2
From BugSigDB
Needs review
Source: Figure S5D
Description: The relative abundance in genus levels after cocktail treatment
Abundance in Group 1: decreased abundance in B2.2 (gut microbiome remodeling compound)
| NCBI | Quality Control | Links |
|---|---|---|
| Bacteroides | ||
| Escherichia/Shigella sp. |
Revision editor(s): Ifeanyisam
